Clinical trials: Any Solid Oral Medication
Lung Cancer, Small Cell
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors
The purpose of this study is to determine the bioequivalence of the new oral capsule formulation to the currently used oral capsule formulation of topotecan.
- Trial name
- NCT00259935
- Testing
- topotecan
- Where
- 8 sites in United States, Netherlands
- Volunteers
- 107 people
- Sponsor
- GlaxoSmithKline
Any Solid Oral Medication
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Primary Objective: To assess the persistence of ReX technology platform use, measured by the percentage (%) of participants who used ReX: 1) throughout the study period and 2) before the treatment discontinuation.
- Trial name
- NCT06344416
- Testing
- Use of ReX to dispense and monitor solid oral medication therapy.
- Where
- 4 sites in United States
- Volunteers
- 200 people
- Sponsor
- Dosentrx Ltd.
Any Solid Oral Medication
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.
The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication.
- Trial name
- RegStud (NCT06335758)
- Testing
- Use of ReX to dispense and monitor solid oral medication therapy.
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- Dosentrx Ltd.